Increasing hepatitis B vaccination coverage and decreasing hepatitis B co-infection prevalence among people with HIV-1 in Germany, 1996-2019. Results from a cohort study primarily in men who have sex with men

  • Published on 16/11/2023
  •  Reading time: 6 min.

A. Krings 1, D. Schmidt 1, C. Kollan 1, K. Meixenberger 2, N. Bannert 2, D. Münstermann 3, C. Tiemann 3, V. Bremer 1, B. Gunsenheimer‐Bartmeyer 1, the German HIV‐1 Seroconverter Study Group

1 Department of Infectious Disease Epidemiology Robert Koch Institute Berlin Germany
2 Department of Infectious Diseases Robert Koch Institute Berlin Germany
3 MVZ Labor Krone GbR Bad Salzuflen Germany


Objectives Viral hepatitis co‐infection among people living with HIV is known to accelerate the progression of liver disease and AIDS. An increased prevalence and incidence of hepatitis B virus (HBV) infection among people living with HIV demands continuous monitoring to adapt targeted prevention strategies to reach the global goals of eliminating viral hepatitis as a public health threat.
Methods We determined the prevalence and incidence of HBV...


To continue reading this article in Full-Text...

* Registration is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Infectious Diseases

Receive our newsletter to stay up to date with the latest news in Infectious Diseases

More articles

From peer-reviewed journals in Infectious Diseases